Expected Control Arm Outcomes

Hanny estimates ~20–30% steroid-only durable responses and explains relapse patterns affecting the trial's primary endpoint.

Play episode from 01:46

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!